Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its price target dropped by equities research analysts at Barclays from $230.00 to $200.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has an “overweight” rating on the specialty pharmaceutical company’s stock. Barclays‘s target price indicates a potential upside of 82.08% […]
Barclays Trims Jazz Pharmaceuticals (NASDAQ:JAZZ) Target Price to $200 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Jazz Pharmaceuticals (NASDAQ:JAZZ) Reaches New 52-Week Low at $103 01 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report)’s stock price reached a new 52-week low during trading on Thursday . The company traded as low as $103.01 and last traded at $107.02, with a volume of 161874 shares. The stock had previously closed at $110.31. Analyst Upgrades and Downgrades JAZZ has been the topic of […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its price objective lifted by equities research analysts at JPMorgan Chase & Co. from $170.00 to $190.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has an “overweight” rating on the specialty pharmaceutical company’s stock. JPMorgan Chase & Co.‘s target price […]